Combined targeting of JAK2 and Bcl-xL/Bcl-2 as a novel curative treatment for malignancies expressing mutant JAK2 and overcoming acquired resistance to single agent JAK2 inhibitors
Ontology highlight
ABSTRACT: This SuperSeries is composed of the SubSeries listed below. Refer to individual Series
ORGANISM(S): Mus musculus
SUBMITTER: Jacques GHYSDAEL
PROVIDER: E-GEOD-51250 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA